Please register below to join us for the next virtual Journal Club event, where we will be discussing the publication: In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy.

Date: Wednesday, April 27, 2022

Time: 10-11am PT  /  12-1pm CT